Stop Two

Manufacturer
Immuvet | Amino Cell, Inc.
Effective date
2025-11-04
Label type
PRESCRIPTION ANIMAL DRUG LABEL
Version
8
Source
full-release
Hydrated at
2026-06-01 02:37:20

Label at a glance#

ProductStop Two
Active ingredientANTIMONY POTASSIUM TARTRATE, SILVER NITRATE, IPECAC, MERCURIUS SOLUBILIS, SODIUM SULFATE, PARIS QUADRIFOLIA, PHOSPHORUS, RUMEX CRISPUS ROOT
Label structure9 sections

Indications and uses

Prevention of equine Exercise-Induced Pulmonary Hemorrhage (EIPH) Stop Two® Injection Solution is a homeopathic drug product indicated for the prevention of Exercise-Induced Pulmonary Hemorrhage (EIPH) in horses and camels.

Dosage and administration

General Considerations Stop Two ® Injection solution is to be administered i.v. •   Only licensed veterinarians with sufficient expertise in injecting drugs should administer the  product. Standard Dosage - for the prevention of equine Exercise-Induced Pulmonary Hemorrhage (EIPH): 10cc administered 48 hours before strenuous activity 20cc administered 24 hours before strenuous activity Shake 10 times prior to use

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

Ingredient name               Potency   

Antimon Tartaricum          50x

Argentum Nitricum           200x

Ipecacuanha                    30x

Mercurius Solubilis           60x

Natrum Sulph                  60x

Paris Quadrifolia              200x

Phosphorus                     15x, 200x

Rumex Crispus                30x

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Prevention of equine Exercise-Induced Pulmonary Hemorrhage (EIPH)

  • Stop Two® Injection Solution is a homeopathic drug product indicated for the prevention of Exercise-Induced Pulmonary Hemorrhage (EIPH) in horses and camels.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

General Considerations

  • Stop Two® Injection solution is to be administered i.v.

•   Only licensed veterinarians with sufficient expertise in injecting drugs should administer the  product.

Standard Dosage - for the prevention of equine Exercise-Induced Pulmonary Hemorrhage (EIPH):

10cc administered 48 hours before strenuous activity

20cc administered 24 hours before strenuous activity

Shake 10 times prior to use

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

  • There are no known contraindications for Stop Two® Injection solution.

WARNINGS AND PRECAUTIONS

WARNINGS AND PRECAUTIONS SECTION

None

ADVERSERE REACTIONS

ADVERSE REACTIONS SECTION

Post-marketing Experience

• There have been no adverse reactions reported to date.

To report SUSPECTED ADVERSE REACTIONS, contact Immuvet at (352) 291-0200 or info@immuvet.com

OVERDOSAGE

OVERDOSAGE SECTION

No negative effects of an overdose have been reported and none are expected due to the homeopathic dilutions.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Mechanism of Action

The exact mechanism of Stop Two® Injection solution is not fully understood.

Pharmacodynamics

Not applicable for homeopathic medicinal products.

Package Label - Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Stop Two Injection™
Sterile Injectable Solution
100 mL Sterile Multiple Dose Vial
To reduce the incidence and severity of EIPH (bleeding) in performance horses and camels.
Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Net contents:
100 mL

image descriptionimage description

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130864591000104GTIN-13: 0864591000104
EAN-13: 0864591000104
GTIN-12: 864591000104
UPC-A: 864591000104
GTIN storage (14 digits): 00864591000104
stop two 020723.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
95250459-30e4-45c1-b08a-993044f49109Product name220250805
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
9badc7be-250a-44ab-aa36-926af3f02679Product name120210527
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
7792dadb-52b6-46b6-8fdf-80b1171065b5Product name120180810
26acd337-b838-40ac-bcbc-05c3b81c8712Product name120170323
6cca4355-1206-91f7-02de-17eef38a8622Product name120140508
751c581a-bf64-2fd7-b3ec-ca02c83e4a00Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59517-1610-2Stop Two100 mL in 1 VIAL, MULTI-DOSEINJECTION1008

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
59517-161059517-1610-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML · Source PDF

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
72024-12-23full-release2026-06-01 02:29:48

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 11 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Antimonium tartaricumANTIMONY POTASSIUM TARTRATEWashington Homeopathic Products3e89179f-2597-bca0-e063-6394a90a5b072025-09-11WarningsName fallback
generic name: ANTIMONY POTASSIUM TARTRATE
Antimonium tartaricumANTIMONY POTASSIUM TARTRATEBoiron845faacc-2549-d99e-e053-2991aa0a5b852023-12-21Name fallback
generic name: ANTIMONY POTASSIUM TARTRATE
Antimonium tartaricumANTIMONY POTASSIUM TARTRATEBoiron845f7da9-a4cb-27e0-e053-2991aa0a0f402023-12-21Name fallback
generic name: ANTIMONY POTASSIUM TARTRATE
Antimonium tartaricumANTIMONY POTASSIUM TARTRATEBoiron84ec01bd-0308-0bc2-e053-2991aa0ab9352023-12-21Name fallback
generic name: ANTIMONY POTASSIUM TARTRATE
Antimonium tartaricumANTIMONY POTASSIUM TARTRATEBoiron845faacc-2532-d99e-e053-2991aa0a5b852023-12-21Name fallback
generic name: ANTIMONY POTASSIUM TARTRATE
Antimonium tartaricumANTIMONY POTASSIUM TARTRATEBoiron84ebd218-616c-cd1a-e053-2a91aa0a1d9f2023-12-21Name fallback
generic name: ANTIMONY POTASSIUM TARTRATE
Antimonium tartaricumANTIMONY POTASSIUM TARTRATEBoiron845f1b8c-68f3-2012-e053-2991aa0a44692023-07-11Name fallback
generic name: ANTIMONY POTASSIUM TARTRATE
Antimonium tartaricumANTIMONY POTASSIUM TARTRATEBoiron845ff1a6-8dbe-3581-e053-2a91aa0afa412023-05-16Name fallback
generic name: ANTIMONY POTASSIUM TARTRATE
Antimonium tartaricumANTIMONY POTASSIUM TARTRATEBoiron84ec433c-7d1d-958b-e053-2991aa0a5b712023-04-11Name fallback
generic name: ANTIMONY POTASSIUM TARTRATE
Antimonium tartaricumANTIMONY POTASSIUM TARTRATEBoironc3058b00-794a-11e6-b63b-424c583030312023-04-11Name fallback
generic name: ANTIMONY POTASSIUM TARTRATE
Antimonium tartaricumANTIMONY POTASSIUM TARTRATEBoiron845f7da9-a4de-27e0-e053-2991aa0a0f402023-01-05Name fallback
generic name: ANTIMONY POTASSIUM TARTRATE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.